Previsioni del mercato immunoistochimico per l\'Europa fino al 2028 - Impatto del COVID-19 e analisi regionale per applicazione (diagnostica e test antidroga), prodotto (anticorpi, apparecchiature, reagenti e kit) e utente finale (ospedali e laboratori diagnostici, istituti di ricerca e altri)

Introduzione al mercato

L\'Europa è il secondo mercato più grande per l\'immunoistochimica, seguito da Regno Unito, Germania, Francia, Italia, Spagna e resto del mondo. d’Europa sono i principali contributori a questo mercato in questa regione. La Germania ha guidato il mercato durante il periodo di previsione. La Germania ha assistito a un enorme aumento dei casi di cancro negli ultimi anni; ad esempio, secondo il Global Cancer Observatory, nel 2020 sono stati riscontrati un totale di 6.28.519 nuovi casi in entrambi i sessi e di tutte le età, insieme a casi di 69.697 (11,1%) casi di cancro al seno, 67.959 (10,8%) Cancro alla prostata, 64.804 (10,3%) cancro al polmone, 57.528 (9,2%) cancro del colon-retto, 35.147 (5,6%) cancro alla vescica e 333.384 (53%) altri tumori. L\'immunoistochimica è ampiamente utilizzata nella diagnosi e nella gestione del cancro; pertanto, la domanda di immunoistochimica è in aumento nel paese. La prevalenza delle malattie cardiovascolari è in aumento nel paese. La popolazione anziana contribuisce in larga misura all’aumento della prevalenza delle malattie cardiovascolari. I cambiamenti demografici stanno creando sfide importanti per la cura dei pazienti. Anche il numero delle malattie croniche è in costante aumento insieme al crescente invecchiamento della popolazione. Allo stesso tempo aumenta la pressione sui costi nel settore sanitario. Come afferma il Max Planck Institute 2019, nel Paese circa il 30-40% degli adulti soffre di pressione alta. L’incidenza aumenta con l’aumentare dell’età e le persone di età superiore ai 60 anni hanno maggiori probabilità di sviluppare malattie cardiovascolari. L\'IHC sta diventando sempre più popolare nel campo della diagnostica clinica perché viene utilizzato per diagnosticare malattie croniche come cancro, malattie infettive, malattie cardiovascolari e malattie autoimmuni. Pertanto, si prevede che la crescente prevalenza di malattie croniche aumenterà la domanda di soluzioni immunoistochimiche, promuovendo così la crescita del mercato.

I paesi europei, in particolare la Francia, sono fortemente colpiti dall\'epidemia di COVID-19. Gli anticorpi immunoistochimici del coronavirus sono metodi immunologici che possono essere utilizzati per identificare i membri della famiglia Coronaviridae di virus a RNA che infettano uccelli e mammiferi. Di seguito sono elencati gli anticorpi contro gli antigeni espressi da diversi ceppi di coronavirus, come SARS-CoV-2, SARS-CoV, MERS e altri agenti patogeni non umani come il coronavirus felino. I bersagli comuni degli anticorpi del coronavirus includono il nucleocapside (N) e la glicoproteina spike (S). Questi anticorpi sono destinati ad applicazioni immunoistochimiche. L’analisi immunoistochimica mostra il rilevamento di livelli di espressione differenziale del nucleocapside del coronavirus SARS-CoV-2 e dimostra la specificità dell’anticorpo. L\'analisi immunoistochimica del SARS-CoV-2 Coronavirus NP utilizzando l\'anticorpo monoclonale SARS/SARS-CoV-2 Coronavirus NP (B46F) (cat. n. MA1-7404) mostra una colorazione significativa nei tessuti polmonari e placentari umani infetti da SARS-CoV-2 rispetto ai tessuti di controllo senza SARS-CoV-2. Ricercatori del Regno Unito e della Svezia hanno recentemente utilizzato un’immunoistochimica multiplex estremamente sensibile per esaminare l’espressione di ACE2 nei periciti cerebrali di pazienti con sintomi neurologici in pazienti e controlli COVID-19. Hanno anche utilizzato l\'immunofenotipizzazione spaziale per valutare l\'infiammazione nel tessuto cerebrale dei pazienti affetti da COVID-19.

Panoramica e dinamiche del mercato

Il Si prevede che il mercato europeo dell’immunoistochimica crescerà da 631,33 milioni di dollari nel 2021 a 1.022,27 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 7,1% dal 2021 al 2028. I test diagnostici tradizionali venivano generalmente condotti in laboratori con attrezzature costose e dotati di personale qualificato responsabile dell\'esecuzione dei test. Negli ultimi decenni, i test diagnostici sono gradualmente passati dal laboratorio centrale ai siti di test più vicini ai pazienti. La crescente domanda di immunoistochimica, unita alla carenza di personale nei laboratori di immunologia, ha creato la necessità di automazione nell\'immunoistochimica. L\'automazione in immunoistochimica (IHC) offre l\'opportunità di migliorare i livelli di sensibilità, riproducibilità, standardizzazione, oltre ad offrire vantaggi come la riduzione del tempo di lavoro e il risparmio di reagenti. La flessibilità analitica è uno dei fattori essenziali richiesti nei protocolli immunoistochimici. L\'automazione dell\'IHC contribuisce a standardizzare in modo decisivo le tecniche immunoistochimiche. Inoltre, aiuta anche a semplificare i metodi manuali da 16 passaggi in metodi in 5 passaggi che aiutano a ridurre al minimo il numero di personale operativo. Inoltre, l\'immunoistochimica automatizzata garantisce qualità e scarico costanti dei coloranti e migliora la standardizzazione e l\'ottimizzazione delle diverse tecniche. Inoltre, con risultati affidabili e rapidi, l’automazione può fornire i risultati dei test diagnostici più rapidamente, con conseguente riduzione del periodo di ricovero ospedaliero, con conseguente risparmio sui costi. Pertanto, è probabile che i vari vantaggi offerti dall\'automazione nell\'immunoistochimica (IHC) vengano accettati e agiscano come una delle tendenze prevalenti nel mercato europeo nei prossimi anni.

Segmenti chiave del mercato

In termini di prodotto, il segmento degli anticorpi ha rappresentato la quota maggiore del mercato europeo dell\'immunoistochimica nel 2020. In termini di applicazione, il segmento della diagnostica ha detenuto una quota di mercato maggiore di il mercato europeo dell\'immunoistochimica nel 2020. Inoltre, il segmento degli ospedali e dei laboratori diagnostici ha detenuto una quota maggiore del mercato europeo dell\'immunoistochimica in base all\'utente finale nel 2020.

Principali fonti e aziende Elencate

Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato europeo dell\'immunoistochimica sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e dati statistici banca dati, tra gli altri. Le principali società elencate nel rapporto sono Abcam plc; Agilent Technologies, Inc.; Bio SB; BIO-RAD LABORATORI INC.; Tecnologia di segnalazione cellulare, Inc.; Danaher; F. HOFFMANN-LA ROCHE LTD.; MERCK KGaA; PerkinElmer Inc.; e THERMO FISHER SCIENTIFIC INC.

Motivi per acquistare il rapporto

Comprendere il panorama del mercato europeo dell\'immunoistochimica e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte ritorno
Stare al passo con la concorrenza comprendendo i continui cambiamenti panorama competitivo per il mercato europeo dell\'immunoistochimica
Pianificare in modo efficiente fusioni, acquisizioni e accordi di partnership nel mercato europeo dell\'immunoistochimica identificando segmenti di mercato con le vendite probabili più promettenti
Aiuta a prendere decisioni aziendali consapevoli da parte di persone perspicaci e un\'analisi completa delle prestazioni di mercato di vari segmenti del mercato europeo dell\'immunoistochimica
Ottieni previsioni sulle entrate di mercato per il mercato in base ai vari segmenti dal 2021 al 2028 nella regione europea.

Segmentazione del mercato immunoistochimico in Europa

Mercato europeo dell\'immunoistochimica: per prodotto

Attrezzature
- Sistemi di colorazione dei vetrini
- Sistemi di microarray per tessuti
- Sistemi di elaborazione dei tessuti
- Scanner per vetrini
- Altre apparecchiature
Anticorpi
- Anticorpi primari
- Anticorpi secondari
Reagenti
- Colorazioni istologiche
- Reagenti di bloccaggio e fissazione
- Substrati cromogenici
- Reagenti di fissazione
- Stabilizzanti
- Solventi organici
- Enzimi proteolitici
- Diluenti
Kit

Mercato europeo dell\'immunoistochimica - Per applicazione

Diagnostica
- Cancro
- Malattie infettive
- Malattie autoimmuni
- Diabete mellito
- Malattie nefrologiche
- Altro
Test antidroga

Mercato immunoistochimico in Europa - per utente finale

Ospedali e laboratori diagnostici
Istituti di ricerca
Altri

Mercato immunoistochimico in Europa - Per paese

Mercato europeo dell\'immunoistochimica - Profili aziendali

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Immunohistochemistry Market – By Product

1.3.2 Europe Immunohistochemistry Market – By Application

1.3.3 Europe Immunohistochemistry Market – By End User

1.3.4 Europe Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Chronic and Infectious Diseases

5.1.2 Growing R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Issues Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Opportunities in Several Countries

5.4 Future Trends

5.4.1 Use of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – Europe Analysis

6.1 Europe Immunohistochemistry Market Revenue Forecast and Analysis

7. Europe Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 Europe Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. Europe Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. Europe Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 Europe Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. Europe Immunohistochemistry Market – Country Analysis

10.1 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028

10.1.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.1.2.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.1.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.1.3.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.1.4 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.2.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.2.3.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.2.4 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.3 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.3.2.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.3.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.3.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.3.4 France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.4.2.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.4.2.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.4.2.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.4.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.4.3.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.4.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.5 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.5.2.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.5.2.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.5.2.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.5.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.5.3.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.5.4 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.6 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.6.2.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.6.2.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.6.2.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.6.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.6.3.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.6.4 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Europe Immunohistochemistry Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 Cell Signaling Technology, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 PerkinElmer Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Abcam plc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 BIO-RAD LABORATORIES INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Danaher

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Bio SB

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 7. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 9. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 14. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 16. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 21. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22. France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 23. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 25. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 26. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 28. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 29. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 30. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 31. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 32. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 33. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 34. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Application (USD Million)

Table 35. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Diagnostics (USD Million)

Table 36. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by End User (USD Million)

Table 37. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 38. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 39. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 40. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 41. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 42. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 43. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 44. Organic Developments Done By Companies

Table 45. Inorganic developments done by Companies

Table 46. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Immunohistochemistry Market Segmentation

Figure 2. Europe Immunohistochemistry Market Segmentation, By Country

Figure 3. Europe Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. The UK to Show Significant Growth During Forecast Period

Figure 6. Europe and PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to Europe Immunohistochemistry Market

Figure 8. Europe Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. Europe Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. Europe Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Europe Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Europe Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Europe Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Europe Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Europe Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. Europe Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Europe Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Europe Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. Europe Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Europe Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. Europe Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. Europe Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Europe Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. Europe Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Europe Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. Europe Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. Europe Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. Europe Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. Europe Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. Europe Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. Europe Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. Europe Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. Europe Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. Europe Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. Europe Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. Europe Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. Europe Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. Europe Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. Europe Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. Europe Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. Europe: Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 43. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. Germany Immunohistochemistry Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 50. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Previsioni del mercato immunoistochimico per l\'Europa fino al 2028 - Impatto del COVID-19 e analisi regionale per applicazione (diagnostica e test antidroga), prodotto (anticorpi, apparecchiature, reagenti e kit) e utente finale (ospedali e laboratori diagnostici, istituti di ricerca e altri)

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample